Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
inactivated chikungunya vaccine (adsorbed)
- Development stage
- Unknown
- Lead developer
- Zydus Lifesciences
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Zydus Lifesciences is developing an inactivated, adsorbed vaccine for the prevention of chikungunya virus infection. The vaccine is produced using cell culture technology and utilizes the chikungunya parent virus seed strain DEN-AFP-SV130030. It is designed to elicit a protective immune response against the chikungunya virus by presenting inactivated viral particles to the immune system. As of late 2025, the candidate was in the transition from preclinical to Phase I clinical development, with the Indian Central Drugs Standard Control Organisation (CDSCO) requesting protocol revisions before the initiation of first-in-human studies.
- Other names
- Zydus chikungunya vaccineinactivated chikungunya virus vaccine (adsorbed)
Beyond the preview
Go deeper on inactivated chikungunya vaccine (adsorbed).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on inactivated chikungunya vaccine (adsorbed).